Vantage Investment Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$48K Hold
2,776
0.01% 290
2018
Q2
$39K Hold
2,776
0.01% 315
2018
Q1
$43K Hold
2,776
0.01% 308
2017
Q4
$32K Hold
2,776
0.01% 373
2017
Q3
$53K Hold
2,776
0.01% 262
2017
Q2
$67K Hold
2,776
0.02% 223
2017
Q1
$55K Sell
2,776
-25
-0.9% -$558 0.02% 234
2016
Q4
$67K Sell
2,801
-1,009
-26% -$28.1K 0.03% 210
2016
Q3
$106K Sell
3,810
-1,009
-21% -$26.7K 0.05% 159
2016
Q2
$118K Buy
+4,819
New +$137K 0.05% 156

Other funds holding PGEN

Vantage Investment Advisors's PGEN Position: Q3 2018 in Review

Vantage Investment Advisors held its Precigen (PGEN) position steady in Q3 2018 at 2,776 shares worth $48K. The position accounts for 0.01% of the portfolio, ranked #290.

Vantage Investment Advisors first reported a position in PGEN in Q2 2016 and has held it in 10 quarters since. The position peaked at $118K in Q2 2016. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

  • Vantage Investment Advisors held 2,776 shares of Precigen worth $48K as of Q3 2018.
  • Vantage Investment Advisors left its Precigen share count unchanged in Q3 2018.
  • Precigen made up 0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #290 holding.
  • Vantage Investment Advisors first reported a position in Precigen in Q2 2016 and has held it in 10 quarters since.
  • Vantage Investment Advisors's Precigen position peaked at $118K in Q2 2016.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.